Skip to content
10-Q

Quarterly Report

INNOVATION1 BIOTECH INC.

0001477932-23-004071

← back to feed
Filed
May 30, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · May 30, 2023 20.47M sh
Capex Q2 2023 · Feb 28, 2023 $0
Capex Q2 2023 · Feb 28, 2022 $3.14K
Current Liabilities Q2 2023 · Feb 28, 2023 $2.33M
Current Liabilities Q2 2023 · Aug 31, 2022 $29.81M
Total Liabilities Q2 2023 · Feb 28, 2023 $2.36M
Total Liabilities Q2 2023 · Aug 31, 2022 $41.11M
Current Assets Q2 2023 · Feb 28, 2023 $142K
Current Assets Q2 2023 · Aug 31, 2022 $286.96K
Total Assets Q2 2023 · Feb 28, 2023 $3.84M
Total Assets Q2 2023 · Aug 31, 2022 $43.96M
Rd Expense Q2 2023 · Feb 28, 2023 $0
Rd Expense Q2 2023 · Feb 28, 2022 $0
Rd Expense Q2 2023 · Feb 28, 2022 $0
Gross Profit Q2 2023 · Feb 28, 2023 $0
Gross Profit Q2 2023 · Feb 28, 2023 $0
Gross Profit Q2 2023 · Feb 28, 2022 $0
Gross Profit Q2 2023 · Feb 28, 2022 $0
Cost Of Revenue Q2 2023 · Feb 28, 2023 $0
Cost Of Revenue Q2 2023 · Feb 28, 2023 $0
Cost Of Revenue Q2 2023 · Feb 28, 2022 $0
Cost Of Revenue Q2 2023 · Feb 28, 2022 $0
Revenue Q2 2023 · Feb 28, 2023 $0
Revenue Q2 2023 · Feb 28, 2023 $0
Revenue Q2 2023 · Feb 28, 2022 $0
Revenue Q2 2023 · Feb 28, 2022 $0
Operating Cash Flow Q2 2023 · Feb 28, 2022 −$1.97M
Stockholders Equity Q2 2023 · Feb 28, 2022 $42.09M
Stockholders Equity Q2 2023 · Nov 30, 2021 $44.05M
Stockholders Equity Q2 2023 · Aug 31, 2021 −$224.84K
Sga Expense Q2 2023 · Feb 28, 2022 $18.2K
Sga Expense Q2 2023 · Feb 28, 2022 $30.66K
Net Income Q2 2023 · Feb 28, 2022 −$1.78M
Net Income Q2 2023 · Feb 28, 2022 −$2.02M
Net Income Q2 2023 · Nov 30, 2021 −$239.85K
Operating Income Q2 2023 · Feb 28, 2022 −$1.78M
Operating Income Q2 2023 · Feb 28, 2022 −$2.14M